Discontinuation of dual antiplatelet therapy over 12 months after acute coronary syndromes increases risk for adverse events in patients treated with pci: systematic review and meta-analysis

被引:0
|
作者
Colombo, F. [1 ]
D'ascenzo, F. [1 ]
Moretti, C. [1 ]
Omede, P. [1 ]
Fox, K. A. A. [2 ]
Rumsfeld, J. S. [3 ]
Tarantini, G. [4 ]
Biondi-Zoccai, G. [5 ]
Gaita, F. [1 ]
机构
[1] Univ Hosp S Giovanni Battista, Dept Cardiol, Hosp Molinette, Turin, Italy
[2] Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland
[3] Denver VA Med Ctr, Denver, CO USA
[4] Univ Padua, Div Cardiol, Dept Cardiac Thorac & Vasc Sci, Padua, Italy
[5] Univ Roma La Sapienza, Dept Medicosurg Sci & Biotechnol, I-00185 Rome, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P150
引用
收藏
页码:25 / 26
页数:2
相关论文
共 50 条
  • [11] Direct Oral Anticoagulants in Addition to Antiplatelet Therapy for Secondary Prevention After Acute Coronary Syndromes A Systematic Review and Meta-analysis
    Chiarito, Mauro
    Cao, Davide
    Cannata, Francesco
    Godino, Cosmo
    Lodigiani, Corrado
    Ferrante, Giuseppe
    Lopes, Renato D.
    Alexander, John H.
    Reimers, Bernhard
    Condorelli, Gianluigi
    Stefanini, Giulio G.
    JAMA CARDIOLOGY, 2018, 3 (03) : 234 - 241
  • [12] Short dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk patients: Systematic review and meta-analysis
    Bainey, Kevin R.
    Marquis-Gravel, Guillaume
    Macdonald, Blair J.
    Bewick, David
    Yan, Andrew
    Turgeon, Ricky D.
    PLOS ONE, 2023, 18 (09):
  • [13] De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials
    Valgimigli, Marco
    Hong, Sung-Jin
    Gragnano, Felice
    Chalkou, Konstantina
    Franzone, Anna
    da Costa, Bruno R.
    Baber, Usman
    Kim, Byeong-Keuk
    Jang, Yangsoo
    Chen, Shao-Liang
    Stone, Gregg W.
    Hahn, Joo-Yong
    Windecker, Stephan
    Gibson, Michael C.
    Bin Song, Young
    Ge, Zhen
    Vranckx, Pascal
    Mehta, Shamir
    Gwon, Hyeon-Cheol
    Lopes, Renato D.
    Dangas, George D.
    McFadden, Eugene P.
    Angiolillo, Dominick J.
    Leonardi, Sergio
    Heg, Dik
    Calabro, Paolo
    Juni, Peter
    Mehran, Roxana
    Hong, Myeong-Ki
    LANCET, 2024, 404 (10456): : 937 - 948
  • [14] Meta-Analysis of Duration of Dual Antiplatelet Therapy in Acute Coronary Syndrome Treated With Coronary Stenting
    Knijnik, Leonardo
    Fernandes, Marcelo
    Rivera, Manuel
    Cardoso, Rhanderson
    Goyal, Abhinav
    Liberman, Henry
    Sperling, Laurence S.
    McDaniel, Michael C.
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 151 : 25 - 29
  • [15] De-Escalation of Dual Antiplatelet Therapy in Elderly Patients With Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
    Fujisaki, Tomohiro
    Kuno, Toshiki
    Iwagami, Masao
    Miyamoto, Yoshihisa
    Takagi, Hisato
    Briasoulis, Alexandros
    Panaich, Sidakpal
    Latib, Azeem
    Kohsaka, Shun
    CIRCULATION, 2022, 146
  • [16] Net clinical benefit of dual antiplatelet therapy in elderly patients with acute coronary syndrome: A systematic review and meta-analysis
    Fujisaki, Tomohiro
    Kuno, Toshiki
    Iwagami, Masao
    Miyamoto, Yoshihisa
    Takagi, Hisato
    Deharo, Pierre
    Cuisset, Thomas
    Briasoulis, Alexandros
    Panaich, Sidakpal
    Latib, Azeem
    Kohsaka, Shun
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2023, 102 (05) : 788 - 802
  • [17] De-escalation of dual antiplatelet therapy for patients with acute coronary syndrome after percutaneous coronary intervention: a systematic review and network meta-analysis
    De Filippo, Ovidio
    Piroli, Francesco
    Bruno, Francesco
    Bocchino, Pier Paolo
    Saglietto, Andrea
    Franchin, Luca
    Angelini, Filippo
    Gallone, Guglielmo
    Rizzello, Giulia
    Ahmad, Mahmood
    Gasparini, Mauro
    Chatterjee, Saurav
    De Ferrari, Gaetano Maria
    D'Ascenzo, Fabrizio
    BMJ EVIDENCE-BASED MEDICINE, 2024, 29 (03) : 171 - 186
  • [18] A systematic review and meta-analysis of optimal antiplatelet therapy for diabetic patients with acute coronary syndrome
    Rossington, J.
    Brown, O. I.
    Hoye, A.
    EUROPEAN HEART JOURNAL, 2015, 36 : 236 - 236
  • [19] Incidence of Adverse Events at 3 Months Versus at 12 Months After Dual Antiplatelet Therapy Cessation in Patients Treated With Thin Stents With Unprotected Left Main or Coronary Bifurcations
    D'Ascenzo, Fabrizio
    Barbero, Umberto
    Abdirashid, Mohamed
    Trabattoni, Daniela
    Boccuzzi, Giacomo
    Ryan, Nicola
    Quadri, Giorgio
    Capodanno, Davide
    Venuti, Giuseppe
    Muscoli, Saverio
    Tomassini, Francesco
    Autelli, Michele
    Montabone, Andrea
    Wojakowski, Wojciech
    Rognoni, Andrea
    Gallo, Diego
    Parma, Radoslaw
    De Luca, Leonardo
    Figini, Filippo
    Mitomo, Satoru
    Montefusco, Antonio
    Mattesini, Alessio
    Wanha, Wojciech
    Protasiewicz, Marcin
    Smolka, Grzegorz
    Huczek, Zenon
    Rolfo, Cristina
    Cortese, Bernardo
    Chieffo, Alaide
    Kuliczowki, Wiktor
    Nunez-Gil, Ivan
    Morbiducci, Umberto
    Ugo, Fabrizio
    Marengo, Giorgio
    Iannaccone, Mario
    Cerrato, Enrico
    di Mario, Carlo
    Moretti, Claudio
    D'Amico, Maurizio
    Varbella, Ferdinando
    Luscher, Thomas F.
    Sheiban, Imad
    Escaned, Javier
    Romeo, Francesco
    Rinaldi, Mauro
    De Ferrari, Gaetano Maria
    Helft, Gerard
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 125 (04): : 491 - 499
  • [20] Ticagrelor monotherapy after short duration of dual antiplatelet therapy compared to continued dual antiplatelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary interventions: an updated meta-analysis
    Mansuri, Zeeshan
    Ashraf, Hadiah
    Taikadan, Thahsin
    Rajith, Gokul
    Ayesha, Ayesha
    Fatima, Urooj
    Erzinger, Gabriel
    CORONARY ARTERY DISEASE, 2024, 35 (07) : 590 - 597